These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 7252332)

  • 1. Role of chemotactic factor inactivation in neutrophil chemotaxis.
    Tannous R; Cavender-Zylich N; Ginsberg BH
    J Lab Clin Med; 1981 Aug; 98(2):238-50. PubMed ID: 7252332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotactic factor inactivator interaction with Gc-globulin (vitamin D-binding protein). A mechanism of modulating the chemotactic activity of C5a.
    Robbins RA; Hamel FG
    J Immunol; 1990 Mar; 144(6):2371-6. PubMed ID: 2313096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of chemotactic factor inactivator in modulating alveolar macrophage-derived neutrophil chemotactic activity.
    Robbins RA; Justice JM; Rasmussen JK; Russ WD; Thomas KR; Rennard SI
    J Lab Clin Med; 1987 Feb; 109(2):164-70. PubMed ID: 3805869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigenic identification of chemotactic factor inactivator in normal human serum and bronchoalveolar lavage fluid.
    Robbins RA; Rasmussen JK; Clayton ME; Gossman GL; Kendall TJ; Rennard SI
    J Lab Clin Med; 1987 Sep; 110(3):292-9. PubMed ID: 3611952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical quantitation of the chemotactic factor inactivator activity in human serum.
    Fantone J; Senior RM; Kreutzer DL; Jones M; Ward PA
    J Lab Clin Med; 1979 Jan; 93(1):17-24. PubMed ID: 759526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of chemotactic factor inactivator by cigarette smoke. A potential mechanism of modulating neutrophil recruitment to the lung.
    Robbins RA; Gossman GL; Nelson KJ; Koyama S; Thompson AB; Rennard SI
    Am Rev Respir Dis; 1990 Oct; 142(4):763-8. PubMed ID: 2221580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Group B streptococci inhibit the chemotactic activity of the fifth component of complement.
    Hill HR; Bohnsack JF; Morris EZ; Augustine NH; Parker CJ; Cleary PP; Wu JT
    J Immunol; 1988 Nov; 141(10):3551-6. PubMed ID: 3053900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotactic activity generated in human serum from the fifth component of complement by hydrogen peroxide.
    Shingu M; Nobunaga M
    Am J Pathol; 1984 Nov; 117(2):201-6. PubMed ID: 6388344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevation of serum chemotactic factor inactivator activity in rabbits induced by inflammation and chemotactic factor.
    Hupp JR; Despins AW; McCormick JR; Armstrong G; Kreutzer DL
    Am J Pathol; 1982 Dec; 109(3):277-82. PubMed ID: 7180941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional loss of chemotactic factor inactivator in the adult respiratory distress syndrome.
    Robbins R; Maunder R; Gossman G; Kendall T; Hudson L; Rennard S
    Am Rev Respir Dis; 1990 Jun; 141(6):1463-8. PubMed ID: 2350087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased chemotactic activity in activated newborn plasma.
    Tannous R; Spitzer RE; Clarke WR; Goplerud CP; Cavendar-Zylich N
    J Lab Clin Med; 1982 Mar; 99(3):331-41. PubMed ID: 7057060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of chemotactic activity developed by neutrophils from rheumatoid arthritis patients.
    Bostan M; Constantin MC; Nicolau A; Hirt M; Galatiuc C; Matei I; Braşoveanu LI; Iordăchescu D
    Roum Arch Microbiol Immunol; 2002; 61(4):243-58. PubMed ID: 15055258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antileukotactic properties of tumor cells.
    Brozna JP; Ward PA
    J Clin Invest; 1975 Sep; 56(3):616-23. PubMed ID: 239965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in activities of anaphylatoxin inactivator and chemotactic factor inactivator during hemodialysis.
    McCormick JR; Kreutzer DL; Keating HJ; Hupp J; Despins A; Moore M
    Am J Pathol; 1982 Dec; 109(3):283-7. PubMed ID: 7180942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of selected variables in the under-agarose assay for chemotactic responses of canine neutrophils.
    Nagahata H; Kociba GJ; Reiter JA; Couto CG
    Am J Vet Res; 1991 Jun; 52(6):965-9. PubMed ID: 1883103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevation of serum chemotactic factor inactivator activity during acute inflammatory reactions in patients with hypersensitivity pneumonitis.
    Kreutzer DL; McCormick JR; Thrall RS; Hupp JR; Moore VL; Fink JN
    Am Rev Respir Dis; 1982 May; 125(5):612-4. PubMed ID: 7081823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement component C5 is required for release of alveolar macrophage-derived neutrophil chemotactic activity.
    Robbins RA; Russ WD; Thomas KR; Rasmussen JK; Kay HD
    Am Rev Respir Dis; 1987 Mar; 135(3):659-64. PubMed ID: 3826892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inhibitory effect of heparin and related glycosaminoglycans on neutrophil chemotaxis.
    Matzner Y; Marx G; Drexler R; Eldor A
    Thromb Haemost; 1984 Oct; 52(2):134-7. PubMed ID: 6084320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-8 secretion in patients with allergic rhinitis after an allergen challenge: interleukin-8 is not the main chemotactic factor present in nasal lavages.
    Gosset P; Tillie-Leblond I; Malaquin F; Durieu J; Wallaert B; Tonnel AB
    Clin Exp Allergy; 1997 Apr; 27(4):379-88. PubMed ID: 9146930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amplification of the activity of human leukocyte inhibitory factor (LIF) by the generation of a low molecular weight inhibitor of PMN leukocyte chemotaxis.
    Goetzl EJ; Rocklin RE
    J Immunol; 1978 Sep; 121(3):891-6. PubMed ID: 690441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.